Influencia de los trastornos psiquiátricos y la terapia de sustitución con opiáceos en el tratamiento del virus de la hepatitis c con antivirales de acción directa en usuarios de drogas por vía parenteral

Fernández de Cañete Camacho, José Carlos; Mancebo Martínez, Antonio; García Mena, María Adela; Moreno Planas, José María.
Gastroenterol. hepatol. (Ed. impr.) ; 45(4): 265-273, Abr. 2022. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-204220

Documentos relacionados

  1. Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study.
  2. Influence of psychiatric disorders and opioid substitution therapy on hepatitis C treatment with direct-acting antivirals in people who inject drugs.
  3. Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs.
  4. Validation of Self-reported Opioid Agonist Treatment Among People Who Inject Drugs Using Prescription Dispensation Records.
  5. [Antiviral treatment for hepatitis C among injecting drug users in the era of direct-acting antiviral agents].
  6. Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study.
  7. Overall, Direct, Spillover, and Composite Effects of Components of a Peer-Driven Intervention Package on Injection Risk Behavior Among People Who Inject Drugs in the HPTN 037 Study.
  8. Inpatient Hepatitis C Treatment Coordination and Initiation for Patients Who Inject Drugs.
  9. Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users.
  10. Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial.